BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23549928)

  • 1. Ranking sources of hospital quality information for orthopedic surgery patients: consequences for the system of managed competition.
    Bes RE; van den Berg B
    Patient; 2013; 6(2):75-80. PubMed ID: 23549928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring Healthcare Providers' Performances Within Managed Competition Using Multidimensional Quality and Cost Indicators.
    Portrait FR; van der Galiën O; Van den Berg B
    Health Econ; 2016 Apr; 25(4):408-23. PubMed ID: 25702821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition policy for health care provision in the Netherlands.
    Schut FT; Varkevisser M
    Health Policy; 2017 Feb; 121(2):126-133. PubMed ID: 27923494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advice from the health insurer as a channelling strategy: a natural experiment at a Dutch health insurance company.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2018 Nov; 18(1):832. PubMed ID: 30400978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system.
    Boonen LH; Schut FT
    Health Econ Policy Law; 2011 Apr; 6(2):219-35. PubMed ID: 21122187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Econ Policy Law; 2021 Jul; 16(3):273-289. PubMed ID: 32690116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policies towards hospital and GP competition in five European countries.
    Siciliani L; Chalkley M; Gravelle H
    Health Policy; 2017 Feb; 121(2):103-110. PubMed ID: 27956096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.
    Brouns C; Douven R; Kemp R
    Health Econ; 2021 Apr; 30(4):803-819. PubMed ID: 33502788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Managed competition" for Ireland? The single versus multiple payer debate.
    Mikkers M; Ryan P
    BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To what degree do patients actively choose their healthcare provider at the point of referral by their GP? A video observation study.
    Potappel AJC; Meijers MC; Kloek C; Victoor A; Noordman J; Olde Hartman T; van Dulmen S; de Jong JD
    BMC Fam Pract; 2019 Dec; 20(1):166. PubMed ID: 31787107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does managed competition constrain hospitals' contract prices? Evidence from the Netherlands.
    Douven R; Burger M; Schut F
    Health Econ Policy Law; 2020 Jul; 15(3):341-354. PubMed ID: 30973119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the reform of the Dutch healthcare into managed competition: Results of a Delphi study among experts.
    de Vries H; Vahl J; Muris J; Evers S; van der Horst H; Cheung KL
    Health Policy; 2021 Jan; 125(1):27-33. PubMed ID: 33189409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective contracting and channelling patients to preferred providers: A scoping review.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    Health Policy; 2017 May; 121(5):504-514. PubMed ID: 28381338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptance of selective contracting: the role of trust in the health insurer.
    Bes RE; Wendel S; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2013 Oct; 13():375. PubMed ID: 24083663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To what degree are health insurance enrollees in the Netherlands aware of the restrictive conditions attached to their policies?
    van der Hulst FJP; Holst L; Brabers AEM; de Jong JD
    Health Policy; 2022 Jul; 126(7):693-703. PubMed ID: 35644719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An assessment of the Dutch experience with health insurers acting as healthcare advisors.
    Victoor A; Brabers AEM; van Esch TEM; de Jong JD
    PLoS One; 2019; 14(11):e0224829. PubMed ID: 31703085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health plan choice in the Netherlands: restrictive health plans preferred by young and healthy individuals.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    Health Econ Policy Law; 2017 Jul; 12(3):345-362. PubMed ID: 28290918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.